Blood Loss, Surgical
Conditions
Brief summary
This randomised controlled trial has a non-inferiority design. The aim is to test if the blood loss (volume in mL and hemoglobin) is effected by heart and lung cardiotomy retransfusion, or not? Forty CABG (Coronary Artery By pass Grafting) patients will be allocated to either receive retransfusion (n=20) of cardiotomy blood via the heart and lung mashine, or no retransfusion (n=20).
Interventions
PROCEDURENo retransfusion of cardiotomy blood
No retransfusion of cardiotomy blood via heart- and lung mashine
Sponsors
Örebro University, Sweden
Study design
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Masking description
The person that controle the heart- and lung mashine is not masked. Other members of the surgical team is masked.
Intervention model description
Randomised controlled non-inferiority trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Elective CABG.
Exclusion criteria
* Anaemia, infection, massive bleeding, CABG off pump.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| blood loss | During 5 days hemoglobin will be measured as the clinical rutine or as needed. | Hemoglobin |
| Blood loss | During 2 days or while surgical drains remains, blood volume in mL is measured. | Blood volume in millilitre (mL) |
Countries
Sweden
Contacts
Primary ContactCamilla Wistrand, PhD
Outcome results
None listed